Aytu Biopharma Inc
AYTU2.390USD
+0.090+3.91%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
23.69MMarket Cap
LossP/E TTM
More Details of Aytu Biopharma Inc Company
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Aytu Biopharma Inc Info
Ticker SymbolAYTU
Company nameAytu Biopharma Inc
IPO dateOct 20, 2017
CEODisbrow (Joshua R)
Number of employees82
Security typeOrdinary Share
Fiscal year-endOct 20
Address7900 E. Union Avenue
CityDENVER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code80237
Phone17204376580
Websitehttps://aytubio.com/
Ticker SymbolAYTU
IPO dateOct 20, 2017
CEODisbrow (Joshua R)
Company Executives of Aytu Biopharma Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+32106.00%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+33743.00%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+12291.00%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+10000.00%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+10000.00%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
ADHD portfolio
13.16M
94.73%
Pediatric portfolio
715.00K
5.15%
Other
17.00K
0.12%
Shareholding Stats
Updated: Fri, Feb 6
Updated: Fri, Feb 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
Other
70.66%
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
8.31%
AWM Investment Company, Inc.
5.77%
The Vanguard Group, Inc.
2.60%
Diadema Partners LP
2.54%
Other
70.66%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
15.55%
Hedge Fund
15.19%
Individual Investor
5.13%
Investment Advisor
3.26%
Bank and Trust
0.03%
Other
60.84%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
61
3.62M
34.64%
--
2025Q3
63
3.62M
35.61%
+200.00K
2025Q2
63
3.42M
23.61%
+1.37M
2025Q1
58
1.88M
32.85%
-147.25K
2024Q4
61
1.88M
35.64%
-167.56K
2024Q3
65
2.05M
38.87%
-5.48K
2024Q2
68
2.06M
35.52%
+258.31K
2024Q1
72
1.80M
39.85%
-420.62K
2023Q4
75
1.77M
40.04%
+44.24K
2023Q3
81
1.73M
39.72%
+20.75K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Nantahala Capital Management, LLC
1.09M
10.67%
--
--
Sep 30, 2025
Stonepine Capital Management, LLC
891.86K
8.75%
+79.18K
+9.74%
Sep 30, 2025
AWM Investment Company, Inc.
619.57K
6.08%
-300.00
-0.05%
Sep 30, 2025
The Vanguard Group, Inc.
278.58K
2.73%
+250.69K
+898.94%
Sep 30, 2025
Diadema Partners LP
272.67K
2.68%
+272.67K
--
Sep 30, 2025
Disbrow (Joshua R.)
207.20K
2.03%
+53.95K
+35.20%
Oct 13, 2025
Lytton (Laurence W)
122.06K
1.2%
-384.54K
-75.91%
Sep 30, 2025
Two Sigma Investments, LP
108.54K
1.07%
+73.50K
+209.79%
Sep 30, 2025
Renaissance Technologies LLC
95.12K
0.93%
+5.21K
+5.79%
Sep 30, 2025
Geode Capital Management, L.L.C.
71.01K
0.7%
+17.14K
+31.81%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
